early
experiences
azathioprine
ulcerative
colitis
a
note
caution
azathioprine
administered
patients
ulcerative
colitis
classified
severe
2moderately
severe
relatively
mild
patient
conjunction
standard
therapy
adrenal
corticosteroids
patients
possible
beneficial
therapeutic
effects
azathioprine
small
series
cannot
evaluated
definitively
concurrent
medication
preliminary
uncontrolled
observations
however
clinical
improvement
apparent
patients
patients
favorable
course
occurred
absence
steroid
therapy
additional
patients
favorable
course
maintained
administration
azathioprine
following
discontinuance
prolonged
steroid
therapy
patient
administration
azathioprine
associated
amelioration
arthritis
pyoderma
gangrenosum
respond
use
steroids
medication
immunosuppressive
observations
limited
established
delayed
hypersensitivity
response
reflected
various
skin
tests
unchanged
administration
azathioprine
azathioprine
discernible
toxic
effects
upon
kidneys
liver
patients
postnecrotic
cirrhosis
serum
hepatitis
gastrointestinal
symptoms
anorexia
epigastric
discomfort
nausea
occurred
patients
mild
moderate
leukopenia
developed
patients
individuals
accompanied
thrombocytopenia
temporary
alopecia
occurred
woman
hematopoietic
effects
developed
within
wk
therapy
azathioprine
a
dosage
level
mg/kg/day
azathioprine
exert
rapid
beneficial
effect
ulcerative
colitis
noted
corticotropin
adrenal
corticosteroids
therefore
use
severe
ulcerative
colitis
requiring
intensive
therapy
probably
undesirable
azathioprine
basis
initial
observations
may
considered
moderately
severe
ulcerative
colitis
circumstances
permitting
controlled
prolonged
therapeutic
trial
adjunct
medication
careful
supervision
prevention
toxicity
especially
leukopenia
